Trial Profile
AN HPV16 E6/E7 synthetic overlapping long-peptide vaccine in women with high-grade cervical squamous intraepithelial lesions
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2013
Price :
$35
*
At a glance
- Drugs ISA 101 (Primary)
- Indications Cervical cancer; Cervical intraepithelial neoplasia; Human papillomavirus infections
- Focus Pharmacodynamics
- 01 Sep 2012